Human Arenas
July 10, 2026
Attila Kovács
Abstract Gaming addiction is a complex phenomenon that extends beyond behavioral reinforcement and neurochemical dysregulation. This study adopts a phenomenological approach, integrating Husserl’s active and passive synthesis with Heidegger’s existential structures and Arvidson’s conceptualization of attention, to explore how gaming addiction reshapes reflective awareness, attentional control...
International review of neurobiology
2025
Ede Frecska, Attila Kovács, Attila Szabo
2 citations
This paper explores the therapeutic potential of DMT in neuroprotective strategies, particularly concerning ischemia-reperfusion injury (IRI) and neurodegenerative disorders. Besides its potent serotonin receptor actions, DMT is also an endogenous agonist of the sigma-1 receptor (Sig-1R). Sigma receptors are a unique family of proteins with high expression in the brain and spinal cord and have...
Journal of Neuroscience and Neurological Disorders
April 19, 2024
Attila Kovács, Anna Mathe, Ede Frecska
2 citations
Ischemia-Reperfusion Injury (IRI) is the outcome of two intertwined pathological processes resulting from the shortage of blood flow to tissues and the subsequent restoration of circulation to a previously ischemic area. IRI (sometimes just one side of the dyad) remains one of the most challenging problems in several branches of emergency medicine. Mitochondrial and endoplasmic reticulum...
Biomedicines
April 26, 2022
Anna Szilágyi, Barbara Takács, Réka Szekeres et al.
10 citations
Ischemic eye diseases are major causes of vision impairment. Thus, potential retinoprotective effects of N’N-dimethyltryptamine (DMT) were investigated. To inhibit its rapid breakdown by monoamine-oxidase A (MAO-A) enzyme, DMT was co-administered with harmaline, a β-carboline in the Amazonian Ayahuasca brew. Using ligation, 60 min of ischemia was provoked in eyes of rats, followed by 7 days of...
Frontiers in Neuroscience
September 14, 2016
Attila Szabo, Attila Kovács, Jordi Riba et al.
18 citations
N,N-dimethyltryptamine (DMT) is a potent endogenous hallucinogen present in the brain of humans and other mammals. Despite extensive research, its physiological role remains largely unknown. Recently, DMT has been found to activate the sigma-1 receptor (Sig-1R), an intracellular chaperone fulfilling an interface role between the endoplasmic reticulum (ER) and mitochondria. It ensures the...
PLoS One
2014
Attila Szabo, Attila Kovács, Ede Frecska et al.
191 citations
The orphan receptor sigma-1 (sigmar-1) is a transmembrane chaperone protein expressed in both the central nervous system and in immune cells. It has been shown to regulate neuronal differentiation and cell survival, and mediates anti-inflammatory responses and immunosuppression in murine in vivo models. Since the details of these findings have not been elucidated so far, we studied the effects...